| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $829.5M | -9.3% |
| Cost of Revenue | $187.4M | -16.0% |
| Gross Profit | $642.0M | -7.1% |
| R&D Expense | $161.2M | -8.5% |
| SG&A Expense | $95.9M | -7.4% |
| Operating Income | -$149.8M | -292.9% |
| Interest Expense | $8.7M | -15.6% |
| Pre-tax Income | -$144.5M | -311.2% |
| Income Tax | $3.2M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $389.7M | +0.7% |
| Accounts Receivable | $192.1M | +33.5% |
| Inventory | $14.1M | -21.5% |
| Current Assets | $672.5M | +8.9% |
| Total Assets | $2.60B | -8.0% |
| Current Liabilities | $395.1M | -12.9% |
| Long-term Debt | $100.0M | +0.0% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.8M | -62.5% |
| Capital Expenditures | $6.3M | -39.6% |
| Investing Cash Flow | $13.4M | -12.7% |
| Financing Cash Flow | -$69.4M | +83.5% |
| Free Cash Flow | $52.5M | -64.1% |
| -63.2% |
| Net Income | -$147.7M | -347.7% |
| EPS (Basic) | -$2.07 | -349.4% |
| EPS (Diluted) | -$2.07 | -352.4% |
| Total Liabilities |
| $703.2M |
| -11.1% |
| Stockholders' Equity | $1.89B | -6.8% |